CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,592,403 | +5.0% | 1,471,302 | +20.4% | 0.00% | 0.0% |
| Q3 2022 | $8,184,000 | +204.8% | 1,221,629 | +91.5% | 0.00% | +100.0% |
| Q2 2022 | $2,685,000 | +2194.9% | 638,024 | +1739.1% | 0.00% | – |
| Q1 2022 | $117,000 | -63.1% | 34,693 | -65.6% | 0.00% | – |
| Q4 2021 | $317,000 | +419.7% | 100,784 | +436.1% | 0.00% | – |
| Q3 2021 | $61,000 | -77.0% | 18,800 | -70.1% | 0.00% | – |
| Q2 2021 | $265,000 | -48.6% | 62,977 | -39.1% | 0.00% | – |
| Q1 2021 | $516,000 | +111.5% | 103,490 | +436.2% | 0.00% | – |
| Q4 2020 | $244,000 | +11.9% | 19,300 | -13.1% | 0.00% | – |
| Q3 2020 | $218,000 | +0.9% | 22,200 | +2.3% | 0.00% | – |
| Q2 2020 | $216,000 | -66.1% | 21,700 | -69.9% | 0.00% | – |
| Q1 2020 | $637,000 | -32.2% | 72,128 | -29.1% | 0.00% | – |
| Q4 2019 | $939,000 | -36.7% | 101,733 | -59.7% | 0.00% | – |
| Q3 2019 | $1,483,000 | -38.1% | 252,230 | +26.3% | 0.00% | -100.0% |
| Q2 2019 | $2,396,000 | +163.9% | 199,713 | +165.1% | 0.00% | – |
| Q1 2019 | $908,000 | +42.5% | 75,331 | +48.5% | 0.00% | – |
| Q4 2018 | $637,000 | -53.0% | 50,733 | -44.5% | 0.00% | -100.0% |
| Q3 2018 | $1,356,000 | -20.0% | 91,427 | -9.2% | 0.00% | 0.0% |
| Q2 2018 | $1,694,000 | -54.5% | 100,659 | -38.1% | 0.00% | -50.0% |
| Q1 2018 | $3,723,000 | +105.7% | 162,586 | +132.4% | 0.00% | +100.0% |
| Q4 2017 | $1,810,000 | -1.6% | 69,961 | -43.9% | 0.00% | 0.0% |
| Q3 2017 | $1,839,000 | -72.3% | 124,679 | -73.8% | 0.00% | -83.3% |
| Q2 2017 | $6,634,000 | +1043.8% | 475,548 | +1019.6% | 0.01% | +500.0% |
| Q1 2016 | $580,000 | -66.3% | 42,474 | -53.2% | 0.00% | -50.0% |
| Q4 2015 | $1,721,000 | +136.4% | 90,726 | +133.9% | 0.00% | +100.0% |
| Q3 2015 | $728,000 | +148.5% | 38,793 | +100.7% | 0.00% | – |
| Q1 2015 | $293,000 | -63.0% | 19,333 | -67.5% | 0.00% | -100.0% |
| Q4 2014 | $791,000 | – | 59,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |